Document Detail


Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden.
MedLine Citation:
PMID:  10397694     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
At a young age, ischemic stroke is an uncommon event in which prothrombotic factors are likely to play an important role. In 202 referred cases, 105 men and 97 women, median age 39 years (range, 3 to 50), with a history of ischemic stroke and in 1036 age frequency-matched apparently healthy individuals from the same ethnic background, we have investigated whether inherited prothrombotic conditions increase the risk of ischemic stroke. Neither abnormal plasma levels of natural anticoagulants and fibrinogen nor significant increase of the prothrombin A20210 allele was found in stroke cases compared with controls. Hypertension (odds ratio [OR], 22.61), male sex (OR, 2.30), smoking (OR, 2.78) and alcohol habits (OR, 0.14), a personal history of venous thromboembolism (OR, 4.53), a family history of stroke (OR, 1.93), high circulating levels of fibrinogen (P=0.0190), and total cholesterol (P=0.101) were all independently associated with ischemic stroke. Compared with noncarriers, carriers of the factor V (FV) Leiden mutation (OR, 2.56), and to a lesser extent, of the methylenetetrahydrofolate reductase (MTHFR) TT genotype (OR, 1.60), had an independent higher estimated risk of having a history of ischemic stroke. The relationship with the FV Leiden mutation was greater in women (OR, 3.95). Thus, in addition to established determinants, FV Leiden mutation is independently associated with the occurrence of ischemic stroke in this setting. The greater association in women suggests the possibility of an interaction of this genotype with female hormones.
Authors:
M Margaglione; G D'Andrea; N Giuliani; V Brancaccio; D De Lucia; E Grandone; V De Stefano; P A Tonali; G Di Minno
Related Documents :
18824854 - Hypertriglyceridemia and ischemic stroke.
19019184 - Relationships between lipoprotein components and risk of ischaemic and haemorrhagic str...
17101894 - African american women have poor long-term survival following ischemic stroke.
11932674 - Gender as a primary predictor of outcome after carotid endarterectomy.
12851844 - Effect of the factor vii r353q missense mutation on plasma apolipoprotein b levels: imp...
15369624 - A note on urine trans, trans muconic acid level among a sample of thai police: implicat...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Arteriosclerosis, thrombosis, and vascular biology     Volume:  19     ISSN:  1079-5642     ISO Abbreviation:  Arterioscler. Thromb. Vasc. Biol.     Publication Date:  1999 Jul 
Date Detail:
Created Date:  1999-07-29     Completed Date:  1999-07-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9505803     Medline TA:  Arterioscler Thromb Vasc Biol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1751-6     Citation Subset:  IM    
Affiliation:
Unita' di Aterosclerosi e Trombosi, I.R.C.C.S. "Casa Sollievo della Sofferenza", S. Giovanni Rotondo, Divisione di Ematologia, Unità di Coagulazione, Ospedale "A. Cardarelli", Napoli, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Brain Ischemia / etiology,  genetics*
Child
Child, Preschool
Factor V / genetics*
Female
Genotype
Humans
Male
Methylenetetrahydrofolate Reductase (NADPH2)
Middle Aged
Mutation
Oxidoreductases Acting on CH-NH Group Donors / genetics
Sex Factors
Thrombosis / genetics*
Chemical
Reg. No./Substance:
0/factor V Leiden; 9001-24-5/Factor V; EC 1.5.-/Oxidoreductases Acting on CH-NH Group Donors; EC 1.5.1.20/Methylenetetrahydrofolate Reductase (NADPH2)

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Impaired anticoagulant response to infusion of thrombin in atherosclerotic monkeys associated with a...
Next Document:  Large amounts of vascular endothelial growth factor at the site of hemostatic plug formation in vivo...